Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now(00)

Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now(00)

This image is part of a curated gallery related to Mannkind Proboards: The Truth About Afrezza That Big Pharma Doesn't Want Out.. All visuals are selected to provide relevant visual reference for the topic.


Image gallery: Mannkind Proboards: The Truth About Afrezza That Big Pharma Doesn't Want Out.

Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now MannKind Pivot Design 6 things Big Pharma doesn’t want you to know Access to medicines MSF Partnering MannKind Corporation For diabetes patients, inhaled insulin is shown just as effective as MannKind's Afrezza Manufacturing Facility, California Pharmaceutical